Sichuan Biokin Pharmaceutical Co.,Ltd. (SHA: 688506)

Market Cap	62.77B
Revenue (ttm)	5.80B
Net Income (ttm)	4.21B
Shares Out	401.00M
EPS (ttm)	10.52
PE Ratio	14.88
Forward PE	18.18
Dividend	n/a
Ex-Dividend Date	n/a

Volume	824,751
Open	155.98
Previous Close	157.67
Day's Range	155.09 - 159.92
52-Week Range	76.32 - 215.71
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 31, 2024

About Sichuan Biokin Pharmaceutical Co.,Ltd.

Sichuan Biokin Pharmaceutical Co.,Ltd. engages in the research and development, production, and marketing of small molecule chemical, macromolecular biological, and antibody-drug conjugate drugs in China and internationally. Sichuan Biokin Pharmaceutical Co.,Ltd. was founded in 2006 and is based in Chengdu, China.

• Industry: Pharmaceutical Preparations
• Founded: 2006
• Employees: 2,086
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688506

Financial Performance

In 2023, 688506's revenue was 561.87 million, a decrease of -20.11% compared to the previous year's 703.28 million. Losses were -780.50 million, 176.4% more than in 2022.